Monitor measures early signs of pulmonary oedema:
This article was originally published in Clinica
Israeli company RS Medical Monitoring has developed a device to monitor patients for early signs of pulmonary oedema, a potentially fatal complication associated with acute heart disease. The monitor, which measures changes in the active resistance in the lungs caused by an accumulation of fluids, gives an audio-visual signal if the fluid level exceeds or falls below pre-set levels.
You may also be interested in...
India’s Sun Pharma has been denied leave to appeal against a US court decision rejecting the company’s bid for dismissal of a multi-district antitrust lawsuit.
Former Sandoz executive Hector Armando Kellum has admitted involvement in a US generic price-fixing conspiracy, the US Department of Justice has announced.
The last year of the run up to the full implementation of the MDR has been characterized by a flurry of new documents and measures, but industry is adamant that medtech is heading for a crisis that will impact industry and patients alike.